De novo lipogenesis is elicited dramatically in human hepatocellular carcinoma especially in hepatitis C virus‐induced hepatocellular carcinoma
Abstract Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. Abnormal de novo lipogenesis is reported to be involved in hepatocarcinogenesis. In current study, de novo lipogenesis and its association with patient survival rate were investigated in human HCC samples...
Main Authors: | Shaojian Li, Ruonan Liu, Qinling Pan, Genshu Wang, Daorou Cheng, Jie Yang, Hui Chen, Geyang Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-09-01
|
Series: | MedComm |
Subjects: | |
Online Access: | https://doi.org/10.1002/mco2.15 |
Similar Items
-
Targeting De Novo Lipogenesis and Cholesterol Biosynthesis Simultaneously is a Novel Therapeutic Option for Hepatocellular Carcinoma
by: Liu Q, et al.
Published: (2021-01-01) -
Direct-Acting Antiviral Drugs and Occurrence of Hepatocellular Carcinoma: Unjust or Oppressed
by: Hassany SM, et al.
Published: (2020-06-01) -
Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
by: Chung-Feng Huang, et al.
Published: (2019-03-01) -
HEPATOCELLULAR CARCINOMA. RECENT ADVANCES IN DIAGNOSIS AND TREATMENT
by: T. Y. Chernobrovkina, et al.
Published: (2016-03-01) -
Hepatocellular carcinoma in adult thalassemia patients: an expert opinion based on current evidence
by: Alessandra Mangia, et al.
Published: (2020-08-01)